Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Intervention1: Muhasa Gel: 1 Finger tip Unit of the gel for the area of Palm size, once daily at night for 8 weeks
Control Intervention1: Zimad e Muhasa
: 2.5 gm powder mixed with water to apply over
Sponsors
Jamia Hamdard
Eligibility
Inclusion criteria
Inclusion criteria: The following patients will be included in the study 1) Subjects with any of the following lesions of Basoor Labaniyah: comedones, papules, pustules, nodules associated with itching and erythema. 2) Clinically stable patients. 3) Patients of both genders in age groups of 13 to 40 years. 4) Patients willing to sign the informed consent form and participate in the trial voluntarily. 5) Patients with moderate to severe acne (score of acne 19-38), as per the Global Acne Grading System (GAGS).
Exclusion criteria
Exclusion criteria: 1) Pregnant and lactating women. 2) Women using hormonal contraceptives. 3) Patients suffering from PCOD on the basis Ultrasound and LH: FSH ratio. 4) Patients with chronic systemic disorders like pulmonary, liver, kidney, or heart disease etc. 5) Patients have had chemical or laser peel and artificial UV therapy. 6) Patient using medications that are reported to exacerbate acne. 7) Patients suffering from other concomitant skin diseases like acne fulminans, acne necrotica, psoriasis, eczema etc. 8) Patients who have used isotretinoin in the last six months and systemic antibiotic within past one month. 9) Patients who have used topical anti-acne medications within past two weeks. 10) Any confluent nodule, cyst present.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in GAGS Scale Score Reduction in CADI Score Timepoint: Day 1, Day 14, Day 28, Day 42, Day 56 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Likert Scale for itching, erythema and scarringTimepoint: Day 1, Day 14, Day 28, Day 42, Day 56 | — |
Countries
India
Contacts
Public ContactYasmeen Shamsi
Jamia Hamdard
Outcome results
None listed